Abaloparatide vs Icotrokinra
Overview
Abaloparatide is primarily a bone & joint peptide, while Icotrokinra is used for immune support.
This page compares Abaloparatide and Icotrokinra across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Abaloparatide | Icotrokinra | |
|---|---|---|
| Category | Bone & Joint | Immune Support |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | 80 mcg | — |
| Frequency | daily | — |
| Reported benefits | Bone building, osteoporosis treatment, reduced fracture risk | — |
| Reported side effects | Similar to teriparatide but milder | — |
Key differences
Primary use. Abaloparatide is categorised under Bone & Joint, while Icotrokinra falls under Immune Support. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Abaloparatide: FDA-approved. Icotrokinra: FDA-approved.
Dosing. Abaloparatide is typically dosed at 80 mcg (daily). Typical dosing for Icotrokinra is not catalogued.
Can you stack them?
Some protocols combine peptides, but stacking Abaloparatide and Icotrokinra has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Abaloparatide and Icotrokinra?
- Abaloparatide is primarily a bone & joint peptide, while Icotrokinra is used for immune support. Abaloparatide is FDA-approved for one or more indications, whereas Icotrokinra is FDA-approved for one or more indications.
- What is Abaloparatide used for?
- Advanced bone anabolic.
- What is Icotrokinra used for?
- Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.
- Can you take Abaloparatide and Icotrokinra together?
- Some users combine peptides within a single protocol, but stacking Abaloparatide and Icotrokinra has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Abaloparatide or Icotrokinra FDA-approved?
- Abaloparatide is FDA-approved for one or more indications. Icotrokinra is FDA-approved for one or more indications.
Read the full articles
- Abaloparatide — full monograph: mechanism, research, dosing & references
- Icotrokinra — full monograph: mechanism, research, dosing & references